Clinical Trials

Inclusion Criteria:

• Is at least 18 years of age.
• Has a clinician-confirmed diagnosis of limited or extensive stage SCLC.
• Has an ECOG Performance Status of 0 to 3 at the time of screening.
• Can read, write, and speak English well enough to understand and complete the informed consent form (ICF), take part in the interview process, and complete all study procedures.

Exclusion Criteria:

• Has a clinically significant1 current or past history of a personality disorder, bipolar disorder, schizophrenia or other psychotic disorder, obsessive compulsive disorder, cognitive disorder, post-traumatic stress disorder, or intellectual disability.
• Has a recent (12-month) history of clinically significant1 drug or alcohol abuse or dependence, excluding nicotine.
• Has been hospitalized for COVID-19 within the previous 12 weeks or, at the time of study screening, is experiencing unresolved COVID-19 symptoms from a current or prior case of COVID-19 as any medical condition or disorder (e.g., symptomatic brain metastases; significant cognitive, auditory, or visual impairment) that, in the opiniHn of the site investigator or study director, could compromise participant’s ability to give written informed consent and/or prevent or interfere with his or her ability to comply with study procedures and provide meaningful information about his or her SCLC experience.

Eligibility last updated 2/24/22. Questions regarding updates should be directed to the study team contact.